Skip to main content
Erschienen in: AIDS and Behavior 8/2021

08.03.2021 | Original Paper

African American/Black and Latino Adults with Detectable HIV Viral Load Evidence Substantial Risk for Polysubstance Substance Use and Co-occurring Problems: A Latent Class Analysis

verfasst von: Charles M. Cleland, Marya Gwadz, Linda M. Collins, Leo Wilton, Dawa Sherpa, Caroline Dorsen, Noelle R. Leonard, Sabrina R. Cluesman, Belkis Y. Martinez, Amanda S. Ritchie, Mariam Ayvazyan

Erschienen in: AIDS and Behavior | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Substance use problems are highly prevalent among persons living with (PLWH) in the United States and serve as serious barriers to engagement in HIV care. Yet, in contrast to studies of single substances, little is known about patterns of polysubstance use in this population. Moreover, other risk factors (e.g., financial hardship, incarceration, homelessness, and mental health distress) are also prevalent and complicate HIV management. The present study drew on a cross-sectional survey with African American/Black and Latino (AABL) adult PLWH from low socioeconomic status backgrounds in New York City who were insufficiently engaged in HIV care and evidenced detectable HIV viral load (N = 512). We used latent class analysis (LCA) to explore patterns of polysubstance use and their relationships to financial hardship, incarceration, homelessness, and mental health. LCA yielded three substance use classes: Class 1, a high polysubstance use/high-risk substance use class (9%); Class 2, a polysubstance use/moderate substance use risk class (18%); and Class 3, a moderate polysubstance use/moderate-to-low-risk substance use class (74%). Mental health symptoms were prevalent in all classes, but Class 1 had greater mental health distress than the other two classes. Current homelessness was more prevalent in Classes 1 and 2. We cannot end the HIV epidemic without engaging and treating AABL PLWH who have serious barriers to engagement along the HIV care continuum, and who evidence polysubstance use along with co-occurring risk factors. Clinical settings can develop outreach and engagement approaches to bring this subpopulation of PLWH into care settings, and further, specialized services are needed to successfully screen, treat, and retain them.
Literatur
1.
Zurück zum Zitat Centers for Disease Control and Prevention. Understanding the HIV care continuum. National center for HIV/AIDS, viral hepatitis, STD, and TB prevention. Atlanta: Centers for Disease Control and Prevention; 2019. Centers for Disease Control and Prevention. Understanding the HIV care continuum. National center for HIV/AIDS, viral hepatitis, STD, and TB prevention. Atlanta: Centers for Disease Control and Prevention; 2019.
2.
Zurück zum Zitat Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care: United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;64(4):113–8. Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care: United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;64(4):113–8.
3.
Zurück zum Zitat Thrasher AD, Earp JA, Golin CE, Zimmer CR. Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defic Syndr. 2008;49(1):84–93.PubMed Thrasher AD, Earp JA, Golin CE, Zimmer CR. Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defic Syndr. 2008;49(1):84–93.PubMed
4.
Zurück zum Zitat Siddiqi AE, Hu XH, Hall HI. Mortality among blacks or African Americans with HIV infection: United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2015;64(4):81–6.PubMedPubMedCentral Siddiqi AE, Hu XH, Hall HI. Mortality among blacks or African Americans with HIV infection: United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2015;64(4):81–6.PubMedPubMedCentral
5.
Zurück zum Zitat Siddiqi AE, Hall HI, Hu X, Song R. Population-based estimates of life expectancy after HIV diagnosis: United States 2008–2011. J Acquir Immune Defic Syndr. 2016;72(2):230–6.PubMedPubMedCentral Siddiqi AE, Hall HI, Hu X, Song R. Population-based estimates of life expectancy after HIV diagnosis: United States 2008–2011. J Acquir Immune Defic Syndr. 2016;72(2):230–6.PubMedPubMedCentral
6.
Zurück zum Zitat Dasgupta S, Oster AM, Li J, Hall HI. Disparities in consistent retention in HIV care: 11 states and the District of Columbia, 2011–2013. MMWR Morb Mortal Wkly Rep. 2016;65(4):77–82.PubMed Dasgupta S, Oster AM, Li J, Hall HI. Disparities in consistent retention in HIV care: 11 states and the District of Columbia, 2011–2013. MMWR Morb Mortal Wkly Rep. 2016;65(4):77–82.PubMed
7.
Zurück zum Zitat Eberhart MG, Yehia BR, Hillier A, et al. Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression. J Acquir Immune Defic Syndr. 2015;69(Suppl 1):S37–43.PubMedPubMedCentral Eberhart MG, Yehia BR, Hillier A, et al. Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression. J Acquir Immune Defic Syndr. 2015;69(Suppl 1):S37–43.PubMedPubMedCentral
8.
Zurück zum Zitat Aidala AA, Wilson MG, Shubert V, et al. Housing status, medical care, and health outcomes among people living with HIV/AIDS: a systematic review. Am J Public Health. 2016;106(1):e1-23.PubMedPubMedCentral Aidala AA, Wilson MG, Shubert V, et al. Housing status, medical care, and health outcomes among people living with HIV/AIDS: a systematic review. Am J Public Health. 2016;106(1):e1-23.PubMedPubMedCentral
9.
Zurück zum Zitat Freeman R, Gwadz M, Wilton L, et al. Understanding long-term HIV survivorship among African American/Black and Latinx persons living with HIV in the United States: a qualitative exploration through the lens of symbolic violence. Int J Equity Health. 2020;19(1):1–23. Freeman R, Gwadz M, Wilton L, et al. Understanding long-term HIV survivorship among African American/Black and Latinx persons living with HIV in the United States: a qualitative exploration through the lens of symbolic violence. Int J Equity Health. 2020;19(1):1–23.
10.
Zurück zum Zitat Rice WS, Crockett KB, Mugavero MJ, et al. Association between internalized HIV-related stigma and HIV care visit adherence. J Acquir Immune Defic Syndr. 2017;76(5):482–7.PubMedPubMedCentral Rice WS, Crockett KB, Mugavero MJ, et al. Association between internalized HIV-related stigma and HIV care visit adherence. J Acquir Immune Defic Syndr. 2017;76(5):482–7.PubMedPubMedCentral
11.
Zurück zum Zitat Brincks AM, Shiu-Yee K, Metsch LR, et al. Physician mistrust, medical system mistrust, and perceived discrimination: associations with HIV care engagement and viral load. AIDS Behav. 2019;23(10):2859–69.PubMedPubMedCentral Brincks AM, Shiu-Yee K, Metsch LR, et al. Physician mistrust, medical system mistrust, and perceived discrimination: associations with HIV care engagement and viral load. AIDS Behav. 2019;23(10):2859–69.PubMedPubMedCentral
12.
Zurück zum Zitat Kalichman SC, Eaton L, Kalichman MO, et al. Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS. J Behav Med. 2016;39(6):1056–64.PubMedPubMedCentral Kalichman SC, Eaton L, Kalichman MO, et al. Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS. J Behav Med. 2016;39(6):1056–64.PubMedPubMedCentral
13.
Zurück zum Zitat Gwadz M, Cleland CM, Applegate E, et al. Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav. 2015;19(10):1801–17.PubMedPubMedCentral Gwadz M, Cleland CM, Applegate E, et al. Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav. 2015;19(10):1801–17.PubMedPubMedCentral
14.
Zurück zum Zitat Hartzler B, Dombrowski JC, Crane HM, et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017;21(4):1138–48.PubMedPubMedCentral Hartzler B, Dombrowski JC, Crane HM, et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017;21(4):1138–48.PubMedPubMedCentral
15.
Zurück zum Zitat Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.PubMedPubMedCentral Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.PubMedPubMedCentral
16.
Zurück zum Zitat Miles DRB, Bilal U, Hutton HE, et al. Tobacco smoking, substance use, and mental health symptoms in people with HIV in an urban HIV clinic. J Health Care Poor Underserved. 2019;30(3):1083–102.PubMedPubMedCentral Miles DRB, Bilal U, Hutton HE, et al. Tobacco smoking, substance use, and mental health symptoms in people with HIV in an urban HIV clinic. J Health Care Poor Underserved. 2019;30(3):1083–102.PubMedPubMedCentral
17.
Zurück zum Zitat Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.PubMedPubMedCentral Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.PubMedPubMedCentral
18.
Zurück zum Zitat Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8(4):223.PubMed Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8(4):223.PubMed
19.
Zurück zum Zitat McGowan CC, Weinstein DD, Samenow CP, et al. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PLoS ONE. 2011;6(4):e18462.PubMedPubMedCentral McGowan CC, Weinstein DD, Samenow CP, et al. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PLoS ONE. 2011;6(4):e18462.PubMedPubMedCentral
20.
Zurück zum Zitat Pence BW, Thielman NM, Whetten K, et al. Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast. AIDS Patient Care STDS. 2008;22(11):869–77.PubMedPubMedCentral Pence BW, Thielman NM, Whetten K, et al. Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast. AIDS Patient Care STDS. 2008;22(11):869–77.PubMedPubMedCentral
21.
Zurück zum Zitat Welch KJ. Correlates of alcohol and/or drug use among HIV-infected individuals. AIDS Patient Care STDS. 2000;14(6):317–23.PubMed Welch KJ. Correlates of alcohol and/or drug use among HIV-infected individuals. AIDS Patient Care STDS. 2000;14(6):317–23.PubMed
22.
Zurück zum Zitat Klinkenberg WD, Sacks S, HIV/AIDS Treatment Adherence Health Outcomes Cost Study Group. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16(Suppl 1):S22–42.PubMed Klinkenberg WD, Sacks S, HIV/AIDS Treatment Adherence Health Outcomes Cost Study Group. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16(Suppl 1):S22–42.PubMed
23.
Zurück zum Zitat Gwadz M, de Guzman R, Freeman R, et al. Exploring how substance use impedes engagement along the HIV care continuum: a qualitative study. Front Public Health. 2016;4:62.PubMedPubMedCentral Gwadz M, de Guzman R, Freeman R, et al. Exploring how substance use impedes engagement along the HIV care continuum: a qualitative study. Front Public Health. 2016;4:62.PubMedPubMedCentral
24.
Zurück zum Zitat Lum PJ, Bruce RD. Comorbid substance use among persons with HIV and chronic pain. In: Merlin JS, Selwyn PA, Treisman GJ, Giovanniello AG, editors. Chronic pain and HIV. Hoboken, NJ: Wiley; 2016. p. 78–96. Lum PJ, Bruce RD. Comorbid substance use among persons with HIV and chronic pain. In: Merlin JS, Selwyn PA, Treisman GJ, Giovanniello AG, editors. Chronic pain and HIV. Hoboken, NJ: Wiley; 2016. p. 78–96.
25.
Zurück zum Zitat Brown MJ, Serovich JM, Laschober TC, Kimberly JA. Age and racial disparities in substance use and self-reported viral suppression among men who have sex with men with HIV. Int J STD AIDS. 2018;29(12):1174–82.PubMedPubMedCentral Brown MJ, Serovich JM, Laschober TC, Kimberly JA. Age and racial disparities in substance use and self-reported viral suppression among men who have sex with men with HIV. Int J STD AIDS. 2018;29(12):1174–82.PubMedPubMedCentral
26.
Zurück zum Zitat Earnshaw VA, Bogart LM, Dovidio JF, Williams DR. Stigma and racial/ethnic HIV disparities: moving toward resilience. Stigma Health. 2015;1:60–74. Earnshaw VA, Bogart LM, Dovidio JF, Williams DR. Stigma and racial/ethnic HIV disparities: moving toward resilience. Stigma Health. 2015;1:60–74.
27.
Zurück zum Zitat Storholm ED, Bogart LM, Mutchler MG, et al. Antiretroviral adherence trajectories among black Americans living with HIV. AIDS Behav. 2019;23(8):1985–97.PubMedPubMedCentral Storholm ED, Bogart LM, Mutchler MG, et al. Antiretroviral adherence trajectories among black Americans living with HIV. AIDS Behav. 2019;23(8):1985–97.PubMedPubMedCentral
28.
Zurück zum Zitat Michel L, Carrieri MP, Fugon L, et al. Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention. AIDS Care. 2010;22(9):1136–45.PubMed Michel L, Carrieri MP, Fugon L, et al. Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention. AIDS Care. 2010;22(9):1136–45.PubMed
29.
Zurück zum Zitat Skalski LM, Watt MH, MacFarlane JC, et al. Mental health and substance use among patients in a North Carolina HIV clinic. N C Med J. 2015;76(3):148–55.PubMedPubMedCentral Skalski LM, Watt MH, MacFarlane JC, et al. Mental health and substance use among patients in a North Carolina HIV clinic. N C Med J. 2015;76(3):148–55.PubMedPubMedCentral
30.
Zurück zum Zitat Starks TJ, MacDonell KK, Pennar AL, et al. Drug use among adolescents and young adults with unsuppressed HIV who use alcohol: identifying patterns of comorbid drug use and associations with mental health. AIDS Behav. 2020;24(10):2975–83.PubMed Starks TJ, MacDonell KK, Pennar AL, et al. Drug use among adolescents and young adults with unsuppressed HIV who use alcohol: identifying patterns of comorbid drug use and associations with mental health. AIDS Behav. 2020;24(10):2975–83.PubMed
31.
Zurück zum Zitat Parsons JT, Starks TJ, Millar BM, Boonrai K, Marcotte D. Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence. Drug Alcohol Depend. 2014;139:33–40.PubMedPubMedCentral Parsons JT, Starks TJ, Millar BM, Boonrai K, Marcotte D. Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence. Drug Alcohol Depend. 2014;139:33–40.PubMedPubMedCentral
32.
33.
Zurück zum Zitat Bhalla IP, Stefanovics EA, Rosenheck RA. Clinical epidemiology of single versus multiple substance use disorders: polysubstance use disorder. Med Care. 2017;55:S24–32.PubMed Bhalla IP, Stefanovics EA, Rosenheck RA. Clinical epidemiology of single versus multiple substance use disorders: polysubstance use disorder. Med Care. 2017;55:S24–32.PubMed
34.
Zurück zum Zitat Sandelowski M, Voils CI, Chang Y, Lee EJ. A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care. 2009;21(8):953–66.PubMedPubMedCentral Sandelowski M, Voils CI, Chang Y, Lee EJ. A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care. 2009;21(8):953–66.PubMedPubMedCentral
35.
Zurück zum Zitat Korthuis PT, Zephyrin LC, Fleishman JA, et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS. 2008;22(11):859–67.PubMedPubMedCentral Korthuis PT, Zephyrin LC, Fleishman JA, et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS. 2008;22(11):859–67.PubMedPubMedCentral
36.
Zurück zum Zitat Baum MK, Rafie C, Lai S, et al. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 2010;26(5):511–8.PubMedPubMedCentral Baum MK, Rafie C, Lai S, et al. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 2010;26(5):511–8.PubMedPubMedCentral
37.
Zurück zum Zitat DeLorenze GN, Satre DD, Quesenberry CP, Tsai AL, Weisner CM. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS. 2010;24(11):705–12.PubMedPubMedCentral DeLorenze GN, Satre DD, Quesenberry CP, Tsai AL, Weisner CM. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS. 2010;24(11):705–12.PubMedPubMedCentral
38.
Zurück zum Zitat Brief DJ, Bollinger AR, Vielhauer MJ, et al. Understanding the interface of HIV, trauma, post-traumatic stress disorder, and substance use and its implications for health outcomes. AIDS Care. 2004;16(Suppl 1):S97–120.PubMed Brief DJ, Bollinger AR, Vielhauer MJ, et al. Understanding the interface of HIV, trauma, post-traumatic stress disorder, and substance use and its implications for health outcomes. AIDS Care. 2004;16(Suppl 1):S97–120.PubMed
39.
Zurück zum Zitat Boarts JM, Sledjeski EM, Bogart LM, Delahanty DL. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav. 2006;10(3):253–61.PubMed Boarts JM, Sledjeski EM, Bogart LM, Delahanty DL. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav. 2006;10(3):253–61.PubMed
40.
Zurück zum Zitat Cunningham CO, Sohler NL, Berg KM, Shapiro S, Heller D. Type of substance use and access to HIV-related health care. AIDS Patient Care STDs. 2006;20(6):399–407.PubMed Cunningham CO, Sohler NL, Berg KM, Shapiro S, Heller D. Type of substance use and access to HIV-related health care. AIDS Patient Care STDs. 2006;20(6):399–407.PubMed
41.
Zurück zum Zitat Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. Hoboken, NJ: Wiley; 2013. Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. Hoboken, NJ: Wiley; 2013.
42.
Zurück zum Zitat Gwadz MV, Collins LM, Cleland CM, et al. Using the Multiphase Optimization Strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol. BMC Public Health. 2017;17(1):383.PubMedPubMedCentral Gwadz MV, Collins LM, Cleland CM, et al. Using the Multiphase Optimization Strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol. BMC Public Health. 2017;17(1):383.PubMedPubMedCentral
43.
Zurück zum Zitat Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.PubMedPubMedCentral Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.PubMedPubMedCentral
44.
Zurück zum Zitat Chandler RK, Kahana SY, Fletcher B, et al. Data collection and harmonization in HIV research: the seek, test, treat, and retain initiative at the National Institute on Drug Abuse. Am J Public Health. 2015;105(12):16–2422. Chandler RK, Kahana SY, Fletcher B, et al. Data collection and harmonization in HIV research: the seek, test, treat, and retain initiative at the National Institute on Drug Abuse. Am J Public Health. 2015;105(12):16–2422.
45.
Zurück zum Zitat Hays RD, Spritzer KL, McCaffrey D, et al. The HIV cost and services utilization study (HCSUS) measures of health-related quality of life. Santa Monica, CA: RAND; 1998. Hays RD, Spritzer KL, McCaffrey D, et al. The HIV cost and services utilization study (HCSUS) measures of health-related quality of life. Santa Monica, CA: RAND; 1998.
46.
Zurück zum Zitat WHO Assist Working Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94. WHO Assist Working Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.
47.
Zurück zum Zitat Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.PubMedPubMedCentral Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.PubMedPubMedCentral
48.
Zurück zum Zitat Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMed Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMed
49.
Zurück zum Zitat Prins A, Ouimette P, Kimerling R, et al. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Primary Care Psychiatry. 2003;9(1):9–14. Prins A, Ouimette P, Kimerling R, et al. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Primary Care Psychiatry. 2003;9(1):9–14.
50.
Zurück zum Zitat Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.PubMed Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.PubMed
51.
Zurück zum Zitat Bolck A, Croon M, Hagenaars J. Estimating latent structure models with categorical variables: one-step versus three-step estimators. Polit Anal. 2004;12(1):3–27. Bolck A, Croon M, Hagenaars J. Estimating latent structure models with categorical variables: one-step versus three-step estimators. Polit Anal. 2004;12(1):3–27.
52.
Zurück zum Zitat Holm S. A simple sequentially rejective multiple test procedure. Scand Stat Theory Appl. 1979;6(2):65–70. Holm S. A simple sequentially rejective multiple test procedure. Scand Stat Theory Appl. 1979;6(2):65–70.
53.
Zurück zum Zitat Muthen LK, Muthén L. Mplus [computer software]. CA: Los Angeles; 1998. Muthen LK, Muthén L. Mplus [computer software]. CA: Los Angeles; 1998.
54.
Zurück zum Zitat R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016.
55.
Zurück zum Zitat Tsuyuki K, Pitpitan EV, Levi-Minzi MA, et al. Substance use disorders, violence, mental health, and HIV: differentiating a syndemic factor by gender and sexuality. AIDS Behav. 2017;21(8):2270–82.PubMedPubMedCentral Tsuyuki K, Pitpitan EV, Levi-Minzi MA, et al. Substance use disorders, violence, mental health, and HIV: differentiating a syndemic factor by gender and sexuality. AIDS Behav. 2017;21(8):2270–82.PubMedPubMedCentral
56.
Zurück zum Zitat Friedman MS, Marshal MP, Stall R, et al. Assocations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV. AIDS Care. 2009;21(6):692–700.PubMed Friedman MS, Marshal MP, Stall R, et al. Assocations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV. AIDS Care. 2009;21(6):692–700.PubMed
57.
Zurück zum Zitat Wolitski RJ, Kidder DP, Fenton KA. HIV, homelessness, and public health: critical issues and a call for increased action. AIDS Behav. 2007;11(2):167–71.PubMed Wolitski RJ, Kidder DP, Fenton KA. HIV, homelessness, and public health: critical issues and a call for increased action. AIDS Behav. 2007;11(2):167–71.PubMed
58.
Zurück zum Zitat Baxter AJ, Tweed EJ, Jatikireddi SV, Thomson H. Effects of housing first approaches on health and well-being of adults who are homeless or at risk of homelessness: systematic review and meta-analysis of randomised controlled trials. J Epidemiol Commun Health. 2019;73(5):379–87. Baxter AJ, Tweed EJ, Jatikireddi SV, Thomson H. Effects of housing first approaches on health and well-being of adults who are homeless or at risk of homelessness: systematic review and meta-analysis of randomised controlled trials. J Epidemiol Commun Health. 2019;73(5):379–87.
59.
Zurück zum Zitat Riley ED, Vittinghoff E, Koss CA, et al. Housing first: Unsuppressed viral load among women living with HIV in San Francisco. AIDS Behav. 2019;23:2326–36.PubMedPubMedCentral Riley ED, Vittinghoff E, Koss CA, et al. Housing first: Unsuppressed viral load among women living with HIV in San Francisco. AIDS Behav. 2019;23:2326–36.PubMedPubMedCentral
60.
Zurück zum Zitat Marel C, Sunderland M, Mills KL, et al. Conditional probabilities of substance use disorders and associated risk factors: progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids. Drug Alcohol Depend. 2019;194:136–42.PubMed Marel C, Sunderland M, Mills KL, et al. Conditional probabilities of substance use disorders and associated risk factors: progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids. Drug Alcohol Depend. 2019;194:136–42.PubMed
61.
Zurück zum Zitat McCabe SE, West BT. The 3-year course of multiple substance use disorders in the United States: a national longitudinal study. J Clin Psychiatry. 2017;78(5):e537–44.PubMedPubMedCentral McCabe SE, West BT. The 3-year course of multiple substance use disorders in the United States: a national longitudinal study. J Clin Psychiatry. 2017;78(5):e537–44.PubMedPubMedCentral
62.
Zurück zum Zitat Evans EA, Grella CE, Washington DL, Upchurch DM. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Drug Alcohol Depend. 2017;174:128–36.PubMed Evans EA, Grella CE, Washington DL, Upchurch DM. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Drug Alcohol Depend. 2017;174:128–36.PubMed
63.
Zurück zum Zitat Dutra L, Stathopoulou G, Basden SL, et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179–87.PubMed Dutra L, Stathopoulou G, Basden SL, et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179–87.PubMed
64.
Zurück zum Zitat Drake RE, O’Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat. 2008;34(1):123–38.PubMed Drake RE, O’Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat. 2008;34(1):123–38.PubMed
65.
Zurück zum Zitat Priester MA, Browne T, Iachini A, et al. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abuse Treat. 2016;61:47–59.PubMed Priester MA, Browne T, Iachini A, et al. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abuse Treat. 2016;61:47–59.PubMed
66.
Zurück zum Zitat Burnam MA, Watkins KE. Substance abuse with mental disorders: specialized public systems and integrated care. Health Aff. 2006;25(3):648–58. Burnam MA, Watkins KE. Substance abuse with mental disorders: specialized public systems and integrated care. Health Aff. 2006;25(3):648–58.
68.
Zurück zum Zitat Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.PubMed Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.PubMed
69.
Zurück zum Zitat Stoff DM, Mitnick L, Kalichman S. Research issues in the multiple diagnoses of HIV/AIDS, mental illness and substance abuse. AIDS Care. 2004;16(Suppl 1):S1–5.PubMed Stoff DM, Mitnick L, Kalichman S. Research issues in the multiple diagnoses of HIV/AIDS, mental illness and substance abuse. AIDS Care. 2004;16(Suppl 1):S1–5.PubMed
70.
Zurück zum Zitat Soto TA, Bell J, Pillen M, For The HIV/AIDS Treatment Adherence Health Outcomes Cost Study Group. Literature on integrated HIV care: a review. AIDS Care. 2004;16(Suppl 1):43–55. Soto TA, Bell J, Pillen M, For The HIV/AIDS Treatment Adherence Health Outcomes Cost Study Group. Literature on integrated HIV care: a review. AIDS Care. 2004;16(Suppl 1):43–55.
71.
Zurück zum Zitat Weaver MR, Conover CJ, Proescholdbell RJ, et al. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47(4):449–58.PubMed Weaver MR, Conover CJ, Proescholdbell RJ, et al. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47(4):449–58.PubMed
72.
Zurück zum Zitat Kraemer KL, McGinnis KA, Fiellin DA, et al. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans. J Subst Abuse Treat. 2019;103:23–32.PubMedPubMedCentral Kraemer KL, McGinnis KA, Fiellin DA, et al. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans. J Subst Abuse Treat. 2019;103:23–32.PubMedPubMedCentral
73.
Zurück zum Zitat Calsyn RJ, Klinkenberg WD, Morse GA, et al. Recruitment, engagement, and retention of people living with HIV and co-occurring mental health and substance use disorders. AIDS Care. 2004;16(Suppl 1):S56–70.PubMed Calsyn RJ, Klinkenberg WD, Morse GA, et al. Recruitment, engagement, and retention of people living with HIV and co-occurring mental health and substance use disorders. AIDS Care. 2004;16(Suppl 1):S56–70.PubMed
74.
Zurück zum Zitat Mueser KT, Gingerich S. Treatment of co-occurring psychotic and substance use disorders. Soc Work Public Health. 2013;28(3–4):424–39.PubMed Mueser KT, Gingerich S. Treatment of co-occurring psychotic and substance use disorders. Soc Work Public Health. 2013;28(3–4):424–39.PubMed
75.
Zurück zum Zitat Ciketic S, Hayatbakhsh MR, Doran CM, Najman JM, McKetin R. A review of psychological and pharmacological treatment options for methamphetamine dependence. J Subst Use. 2011;17(4):363–83. Ciketic S, Hayatbakhsh MR, Doran CM, Najman JM, McKetin R. A review of psychological and pharmacological treatment options for methamphetamine dependence. J Subst Use. 2011;17(4):363–83.
76.
Zurück zum Zitat Durvasula R, Miller TR. Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis. Behav Med. 2014;40(2):43–52.PubMed Durvasula R, Miller TR. Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis. Behav Med. 2014;40(2):43–52.PubMed
77.
Zurück zum Zitat Van Wormer R, Van Wormer K. Non-abstinence-based supportive housing for persons with co-occurring disorders: a human rights perspective. J Progress Hum Serv. 2009;20(2):152–65. Van Wormer R, Van Wormer K. Non-abstinence-based supportive housing for persons with co-occurring disorders: a human rights perspective. J Progress Hum Serv. 2009;20(2):152–65.
78.
Zurück zum Zitat Vakharia SP, Little J. Starting where the client is: harm reduction guidelines for clinical social work practice. Clin Soc Work J. 2016;45(1):65–76. Vakharia SP, Little J. Starting where the client is: harm reduction guidelines for clinical social work practice. Clin Soc Work J. 2016;45(1):65–76.
79.
Zurück zum Zitat Byrd KK, Hardnett F, Hou JG, et al. Improvements in retention in care and HIV viral suppression among persons with HIV and comorbid mental health conditions: patient-centered HIV care model. AIDS Behav. 2020;24(12):3522–32.PubMed Byrd KK, Hardnett F, Hou JG, et al. Improvements in retention in care and HIV viral suppression among persons with HIV and comorbid mental health conditions: patient-centered HIV care model. AIDS Behav. 2020;24(12):3522–32.PubMed
80.
Zurück zum Zitat Fiellin DA, Weiss L, Botsko M, et al. Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S33–8.PubMed Fiellin DA, Weiss L, Botsko M, et al. Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S33–8.PubMed
81.
Zurück zum Zitat Springer SA, Chen S, Altice FL. Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health. 2010;87(4):592–602.PubMedPubMedCentral Springer SA, Chen S, Altice FL. Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health. 2010;87(4):592–602.PubMedPubMedCentral
82.
Zurück zum Zitat Fanucchi L, Springer SA, Korthuis PT. Medications for treatment of opioid use disorder among persons living with HIV. Curr HIV/AIDS Rep. 2019;16(1):1–6.PubMedPubMedCentral Fanucchi L, Springer SA, Korthuis PT. Medications for treatment of opioid use disorder among persons living with HIV. Curr HIV/AIDS Rep. 2019;16(1):1–6.PubMedPubMedCentral
83.
Zurück zum Zitat Low AJ, Mburu G, Welton NJ, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis. Clin Infect Dis. 2016;63(8):1094–104.PubMedPubMedCentral Low AJ, Mburu G, Welton NJ, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis. Clin Infect Dis. 2016;63(8):1094–104.PubMedPubMedCentral
84.
Zurück zum Zitat Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs-United States, 2016–2019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Supp 5):S239–49.PubMed Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs-United States, 2016–2019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Supp 5):S239–49.PubMed
85.
Zurück zum Zitat Mattick RP, Breen C, Kimber J, Davoli M. (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207. Mattick RP, Breen C, Kimber J, Davoli M. (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207.
86.
Zurück zum Zitat Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy. 2007;18(4):262–70.PubMed Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy. 2007;18(4):262–70.PubMed
87.
Zurück zum Zitat Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622.PubMed Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622.PubMed
88.
Zurück zum Zitat Grella CE, Ostile E, Scott CK, Dennis M, Carnavale J. A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. Int J Drug Policy. 2020;81:102768.PubMed Grella CE, Ostile E, Scott CK, Dennis M, Carnavale J. A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. Int J Drug Policy. 2020;81:102768.PubMed
89.
Zurück zum Zitat Michels II, Stover H. Harm reduction–from a conceptual framework to practical experience: the example of Germany. Subst Use Misuse. 2012;47(8–9):910–22.PubMed Michels II, Stover H. Harm reduction–from a conceptual framework to practical experience: the example of Germany. Subst Use Misuse. 2012;47(8–9):910–22.PubMed
90.
Zurück zum Zitat Feldman MB, Thomas JA, Alexy ER, Irvine MK. Crystal methamphetamine use and HIV medical outcomes among HIV-infected men who have sex with men accessing support services in New York. Drug Alcohol Depend. 2015;147:266–71.PubMed Feldman MB, Thomas JA, Alexy ER, Irvine MK. Crystal methamphetamine use and HIV medical outcomes among HIV-infected men who have sex with men accessing support services in New York. Drug Alcohol Depend. 2015;147:266–71.PubMed
91.
Zurück zum Zitat Goodman-Meza D, Shoptaw S, Weiss RE, et al. Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: results of the LINK LA clinical trial. Drug Alcohol Depend. 2019;202:178–84.PubMedPubMedCentral Goodman-Meza D, Shoptaw S, Weiss RE, et al. Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: results of the LINK LA clinical trial. Drug Alcohol Depend. 2019;202:178–84.PubMedPubMedCentral
92.
Zurück zum Zitat Rajasingham R, Mimiaga MJ, White JM, et al. A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine. AIDS Patient Care STDS. 2012;26(1):36–52.PubMedPubMedCentral Rajasingham R, Mimiaga MJ, White JM, et al. A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine. AIDS Patient Care STDS. 2012;26(1):36–52.PubMedPubMedCentral
93.
Zurück zum Zitat Wechsberg WM, Golin C, El-Bassel N, Hopkins J, Zule W. Current interventions to reduce sexual risk behaviors and crack cocaine use among HIV-infected individuals. Curr HIV/AIDS Rep. 2012;9(4):385–93.PubMedPubMedCentral Wechsberg WM, Golin C, El-Bassel N, Hopkins J, Zule W. Current interventions to reduce sexual risk behaviors and crack cocaine use among HIV-infected individuals. Curr HIV/AIDS Rep. 2012;9(4):385–93.PubMedPubMedCentral
94.
Zurück zum Zitat Rose ME, Grant JE. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry. 2008;20(3):145–55.PubMed Rose ME, Grant JE. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry. 2008;20(3):145–55.PubMed
96.
Zurück zum Zitat Gardner LI, Marks G, Shahani L, et al. Assessing efficacy of a retention-in-care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use. AIDS. 2016;30(7):1111–9.PubMed Gardner LI, Marks G, Shahani L, et al. Assessing efficacy of a retention-in-care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use. AIDS. 2016;30(7):1111–9.PubMed
Metadaten
Titel
African American/Black and Latino Adults with Detectable HIV Viral Load Evidence Substantial Risk for Polysubstance Substance Use and Co-occurring Problems: A Latent Class Analysis
verfasst von
Charles M. Cleland
Marya Gwadz
Linda M. Collins
Leo Wilton
Dawa Sherpa
Caroline Dorsen
Noelle R. Leonard
Sabrina R. Cluesman
Belkis Y. Martinez
Amanda S. Ritchie
Mariam Ayvazyan
Publikationsdatum
08.03.2021
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 8/2021
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-021-03212-0

Weitere Artikel der Ausgabe 8/2021

AIDS and Behavior 8/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.